The European Commission has launched a sector inquiry of the e-commerce sector in Europe. This is a far-reaching competition review of the sector by the European Union ("EU") competition authority.
Morrison & Foerster LLP
On May 6, 2015, the European Commission launched a competition inquiry into the e-commerce sector. This inquiry is one of 16 initiatives that the Commission announced for the creation of a Digital Single Market for Europe
On 15 April 2015, the European Commission (EC) sent a Statement of Objections (preliminary statement of case) to Google...
Eleven years after its entry into force, the EU commitment procedure still appears as a formidable success.
On Mar. 9, 2015, the General Court confirmed the European Commission’s decision prohibiting the proposed merger between Deutsche Börse and NYSE Euronext. The merger—which would have brought together the two largest exchanges in the world for European financial derivatives— was blocked by the Commission in February 2012.
On Feb. 17, 2015, the Court of Justice of the European Union ("CJEU") brought an appeal before the Court of Justice against an order of the General Court...
The European Union's Commissioner for Competition, Margrethe Vestager, who began her five-year mandate on Nov. 1, 2014, has indicated that there is more work to be done on the Commission...
McDermott Will & Emery
FTC Chairwoman Edith Ramirez and Assistant Attorney General William Baer testified before the House Committee on the Judiciary's Subcommittee on Regulatory Reform, Commercial and Antitrust Law on May 15, 2015.
Reverse payments are payments made in connection with the settlement of patent litigation between the manufacturer of a brand-name drug and a competitor seeking to market a generic version of that drug.
Sheppard Mullin Richter & Hampton
Briefly by way of background, New York's Certificate of Public Advantage or COPA regulations came into effect in 2014 to provide a structure for state supervision of collaborative healthcare arrangements.
Submission of an application to manufacture a generic version of a pioneer drug covered by a patent is a technical act of infringement, and enables the pioneer manufacturer to file an infringement lawsuit.
It is important to note what the decision does not mean.
Lewis Brisbois Bisgaard & Smith LLP
Assets sales in bankruptcy proceedings are accomplished pursuant to Section 363 of the Bankruptcy Code.
On April 27, 2015, Applied Materials Inc. and Tokyo Electron Ltd. abandoned their merger plans after facing pushback from the Department of Justice.
Butler Snow LLP
A recent Sixth Circuit decision clarified the minimum standard a plaintiff must meet to prove a claim of below-cost pricing under either the concerted or independent antitrust provisions of the Sherman Act.
Cadwalader, Wickersham & Taft LLP
This acquittal is a reminder to individuals and companies that automatically succumbing to the DOJ's plea-bargain process may not be the best strategy.
Patterson Belknap Webb & Tyler LLP
This is the second installment in our coverage of the DOJ's recent criminal cartel enforcement actions.
McDermott Will & Emery
The type of freight in the alleged conspiracy included heavy equipment, medicines, food, beverages and consumer goods.
The issue of whether a no-AG agreement constitutes a reverse payment is currently pending in three separate appeals in the Third Circuit, and another appeal in the First Circuit.
Corporate antitrust compliance programs often spotlight the dangers of tying arrangements.